NCT04248374 is a NA clinical trial of Taste Intensity in Taste, Altered, sponsored by Purdue University.

Who is sponsoring NCT04248374?

NCT04248374 is sponsored by Purdue University.

What drugs are being tested in NCT04248374?

Interventions in NCT04248374: Taste Intensity.

What condition does NCT04248374 study?

NCT04248374 studies Taste, Altered.

Is NCT04248374 still recruiting?

NCT04248374 is currently completed. Last updated 7 May 2024.

Last reviewed 2024-05-07 · How we verify

NCT04248374

Name: Drug Landscape Pharmaceutical Database
Creator: Drug Landscape
Published: 2026-01-01
License: https://creativecommons.org/licenses/by/4.0/

Fatty Acid Taste Rating With or Without Sour Taste Adaptation

Completed NA Last updated 7 May 2024

What this trial tests

NA trial testing Taste Intensity in Taste, Altered in 38 participants. Completed in 30 December 2020.

Timeline

7 October 2019

Primary endpoint
8 September 2020

30 December 2020

Quick facts

Lead sponsor	Purdue University
Phase	NA
Status	Completed
Study type	INTERVENTIONAL
Allocation	randomized
Design	crossover
Masking	single
Primary purpose	basic science
Enrollment	38
Start date	7 October 2019
Primary completion	8 September 2020
Estimated completion	30 December 2020
Sites	1 location across United States

Drugs / interventions tested

Taste Intensity

Conditions studied

Taste, Altered — all drugs for Taste, Altered →

Sponsor

Purdue University

Who can join

Adults 18 to 65, any sex, with Taste, Altered. Patients with the condition only — healthy volunteers not accepted.

Sponsor's own description

We are trying to figure out whether the fatty acid taste is differentiated from sour taste.

Publications & conference data

No peer-reviewed publications indexed yet for this trial. Completed trials usually publish results within 12-18 months.

Verify or expand the search:

Other recruiting trials for Taste, Altered

Currently open trials in the same condition.

NCT06287294 — An Investigation Into Taste Problems Associated With Xerostomia in Patients With Advanced Cancer · recruiting

Other Purdue University trials

Trials by the same sponsor.

NCT07287774 — Evaluating a Deep Neural Noise-Reduction Algorithm for Hearing Aids · NA · recruiting
NCT07086833 — The Food Environment, Microbial Cysteine Metabolism, and Cancer Disparities · NA · recruiting
NCT06638944 — Wearable Biofeedback for Swallowing Disorders Rehabilitation in Stroke and Parkinson Disease · Phase 2 · recruiting
NCT07048392 — Retrieval-Based Word Learning in Developmental Language Disorder During Book Reading II · NA · recruiting
NCT06258941 — Classroom Break, Cognition, and Fitness in Elementary School Children · Phase 1, PHASE2 · recruiting

Verify against primary sources

ClinicalTrials.gov — authoritative US registry record
WHO ICTRP — international registry index
EU Clinical Trials Register
Sponsor press releases (Google)

Data sources for this page

Trial protocol + status: ClinicalTrials.gov NCT04248374 (US National Library of Medicine, public domain)
Drug + disease cross-links: matched in real time against Drug Landscape's normalised drug + company + condition tables
Sponsor: as reported to ClinicalTrials.gov by Purdue University
Last refreshed: 7 May 2024

Drug Landscape aggregates and links these public records for informational use only. Always verify against the primary source before clinical or regulatory decisions. Canonical URL: https://druglandscape.com/trial/NCT04248374.

Primary sources · FDA · ClinicalTrials.gov · EMA · SEC EDGAR · ChEMBL · Wikidata · full sourcing